OXiGENE (OXGN) Income Statement

Click line-items for a historical chart and %

Research and development	2.08M
General and administrative	1.19M
Restructuring
Total operating costs and expenses	3.26M
Loss from operations	-3.26M
Change in fair value of warrants and other financial instruments
Investment income	26K
Other (expense) income, net	0
Net loss	-3.24M
Basic and diluted net loss per share	-0.12
Weighted-average number of common shares outstanding - Basic and diluted
(1) Includes share based compensation expense as follows :
Total share based compensation expense
(1) Includes share based compensation expense as follows :
Total share based compensation expense
General and administrative
(1) Includes share based compensation expense as follows :
Total share based compensation expense

Entities mentioned with OXGN

View All Entities